Manufacturing has changed in recent years. Computer-controlled machines and computer aided design (CAD) tools are more accessible and more flexible than ever before, opening the industry up to more innovative fabrication methods that can capitalize on new and improving capabilities. As for additive technology, it IS changing the world.
Stratasys, a global leader in applied additive technology solutions, announced a new clinical study is being conducted with the New York University (NYU) School of Medicine – aimed at advancing diagnosis and treatment of complex kidney and prostate tumors through imaging and 3D printing. These patient-specific 3D models of organs and their associated pathologies may empower surgeons and researchers to conduct more accurate pre-operative assessment and inter-operative guidance, potentially improving surgical outcomes.